课题基金 / 基金详情

2010 FASEB Conference "Biological Methylation:From DNA to Histones and Beyond"

2010 FASEB Conference "Biological Methylation:From DNA to Histones and Beyond"
2010年FASEB会议“生物甲基化:从DNA到组蛋白及其他”
批准号:
7911239
负责人:
Paula M. Vertino
金额:
$0.7万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-06-01 至 2011-05-31

项目摘要

项目成果

Paula M. Vertino的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):该提案寻求对2010年美国实验生物学学会联合会(FASEB)夏季研究会议“生物甲基化:从DNA到组蛋白及其他”的部分支持。这将是第九次关于这一主题的双年度会议,将于2010年6月6日至11日在无忧无虑亚利桑那州的无忧无虑度假村举行。 “生物甲基化”会议在历史上采取了独特的方法,综合报道了S-腺苷甲硫氨酸依赖性甲基化的酶学,功能和识别及其对各种生物过程和疾病的影响。在过去的16年里,该会议特别关注与DNA和组蛋白甲基化有关的主题,以及这些表观遗传修饰在发育和疾病中的作用。表观遗传重编程领域的最新进展,涉及在发育和疾病期间重新设置DNA和组蛋白甲基化模式,以及全面评估DNA甲基化和组蛋白甲基化的基因组规模技术的演变,使该领域处于现代生物学的前沿。 会议的一个主要焦点将是表观遗传(DNA,组蛋白)甲基化对基因表达和基因组稳定性的影响,以及甲基化失调对人类疾病,特别是癌症的贡献。本次会议的新内容是强调表观遗传“重编程”以及DNA和蛋白质甲基化在细胞/行为对环境压力的反应中的作用。其他会议涉及DNA和蛋白质甲基转移酶/脱甲基酶的结构和功能,以及非组蛋白蛋白的翻译后甲基化,这已成为一个令人兴奋的新研究领域,在转录调控和DNA损伤反应中起着重要作用。 本次会议由来自美国和国外一系列学术和研究机构的初级和高级科学家组成。会议的一个主要目标是促进初级科学家(博士后研究员,研究生)和更资深的既定研究人员之间的互动。会议形式包括九次全体会议(36位特邀演讲者),两次“最新进展”小型会议(由12位从提交的摘要中选出的演讲者组成)和两次海报会议。将为预计的120-150名与会者提供充足的时间进行非正式的社交和互动。 公共卫生相关性:DNA和蛋白质等细胞大分子经常被称为“甲基化”的小化学标签修饰。这种修饰在决定基因组如何包装和阅读以及蛋白质如何共同发挥细胞功能方面发挥着重要作用。甲基化模式在发育过程中受到严格控制,表观遗传甲基化的改变有助于人类疾病,特别是癌症。 该提案要求为题为“生物甲基化:从DNA到组蛋白及其他“的会议提供部分资金。大约150名科学家将参加协调,交流和传播有关控制表观遗传甲基化的潜在机制的信息,并探索甲基化失调对人类疾病的贡献。
英文摘要
DESCRIPTION (provided by applicant): This proposal seeks partial support for the 2010 Federation of American Societies for Experimental Biology (FASEB) Summer Research Conference on "Biological Methylation: From DNA to Histones and Beyond". This will be the ninth biennial conference on this topic and will be held from June 6-11, 2010 at the Carefree Resort in Carefree AZ. The "Biological Methylation" conference has historically taken a unique approach in its integrative coverage of the enzymology, function, and recognition of S-adenosylmethionine- dependent methylation and its influence on diverse biological processes and disease. Over the last sixteen years, this meeting has evolved a particular focus on topics relating to DNA and histone methylation, and the role of these epigenetic modifications in development and disease. Recent advances in the areas of epigenetic reprogramming, which involves the resetting of DNA and histone methylation patterns during development and disease, and the evolution of genome-scale technologies to comprehensively evaluate DNA methylation and histone methylation have put this field at the forefront of modern biology. A major focus of the conference will be the influence of epigenetic (DNA, histone) methylation on gene expression and genome stability, and the contribution of dysregulated methylation to human diseases, particularly cancer. New to this meeting is an emphasis on epigenetic 'reprogramming' and the contribution of DNA and protein methylation in the cellular /behavioral responses to environmental stress. Other sessions deal with the structure and function of DNA and protein methyltransferases/ demethylases, and the posttranslational methylation of non-histone proteins, which has emerged as an exciting new area of study, with central roles in the regulation of transcription and the DNA damage response. This conference is attended by a diverse group of junior and senior scientists from a range of academic and research institutions in the US and abroad. A major goal of the meeting is to promote interaction between junior scientists (postdoctoral fellows, graduate students) and more senior established investigators. The conference format includes nine plenary sessions (36 invited speakers), two "Recent Advances" minisymposia (consisting of 12 speakers selected from submitted abstracts), and two poster sessions. Ample time will be provided for the 120-150 expected participants to socialize and interact on an informal basis. PUBLIC HEALTH RELEVANCE: Cellular macromolecules such as DNA and proteins are frequently modified with a small chemical tag called 'methylation'. This modification plays a fundamental role in determining how the genome is packaged and read, and how proteins act together to carry out cellular functions. Patterns of methylation are strictly controlled during development and alterations in epigenetic methylation contribute to human disease, particularly cancer. The proposal requests partial funding for a conference entitled "Biological Methylation: from DNA to Histones and Beyond ". Approximately 150 scientists will attend to coordinate, exchange, and disseminate information on the underlying mechanisms controlling epigenetic methylation and to explore the contribution of dysregulated methylation to human disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Relaxed Polymerase Pausing as a Driver of Epigenetic Plasticity and Cancer Cell Invasion
  • 批准号:
    10600087
  • 项目类别:
  • 资助金额:
    $40.91万
  • 财政年份:
    2021
  • 负责人:
    Paula M. Vertino
  • 依托单位:
Relaxed Polymerase Pausing as a Driver of Epigenetic Plasticity and Cancer Cell Invasion
  • 批准号:
    10747536
  • 项目类别:
  • 资助金额:
    $6.26万
  • 财政年份:
    2021
  • 负责人:
    Paula M. Vertino
  • 依托单位:
Relaxed Polymerase Pausing as a Driver of Epigenetic Plasticity and Cancer Cell Invasion
  • 批准号:
    10378710
  • 项目类别:
  • 资助金额:
    $41.3万
  • 财政年份:
    2021
  • 负责人:
    Paula M. Vertino
  • 依托单位:
Cancer GENETICS AND EPIGENETICS
  • 批准号:
    8512116
  • 项目类别:
  • 资助金额:
    $3.02万
  • 财政年份:
    2012
  • 负责人:
    Paula M. Vertino
  • 依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
  • 批准号:
    2021JJ40433
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2021
  • 负责人:
    孙磊
  • 依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
  • 批准号:
    32001603
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    段真珍
  • 依托单位:
AREA国际经济模型的移植.改进和应用
  • 批准号:
    18870435
  • 项目类别:
    面上项目
  • 资助金额:
    2.0万元
  • 批准年份:
    1988
  • 负责人:
    史树中
  • 依托单位: